BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:ACP-211 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of ACP-211\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07284667-815@assetmemo.bio
DTSTAMP:20261121T004054Z
DTSTART;VALUE=DATE:20270831
DTEND;VALUE=DATE:20270901
SUMMARY:ACP-211: Phase 2 readout est. (NCT07284667)
DESCRIPTION:ACP-211\, phase 2\, Major Depressive Disorder.\nStudy: ACP-211 
 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant R
 esponse\nEstimated primary completion: August 2027. This is a ClinicalTria
 ls.gov estimate\, not a confirmed readout date\, and it can move.\nDrug pa
 ge: https://assetmemo.bio/drug/acp-211#upcoming-events\nRegistry record: h
 ttps://clinicaltrials.gov/study/NCT07284667
URL:https://assetmemo.bio/drug/acp-211#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
